TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating ...
This news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward looking information is frequently ...
As reported by Mindset, the tie-up consists of a US$5 million upfront cash payment and operational support to develop two 2nd generation psychedelic families in Mindset's pipeline through phase 1a and ...
Indian pharma industry is currently facing the challenge of dealing with data integrity issues during the international regulatory inspections despite the remarkable progress of the sector in the ...
Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. Mindset Pharma NewsMORE Indices Commodities Currencies Stocks ...
Toronto, Ontario--(Newsfile Corp. - March 10, 2021) - Mindset Pharma Inc. (CSE:MSET) (FSE: 9DF) ("Mindset" or the "Company"), a biotechnology company focused on developing next generation psychedelic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results